Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-097010
Filing Date
2024-08-14
Accepted
2024-08-14 16:10:20
Documents
40
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q kod-20240630.htm   iXBRL 10-Q 1627221
2 EX-31.1 kod-ex31_1.htm EX-31.1 16200
3 EX-31.2 kod-ex31_2.htm EX-31.2 16184
4 EX-32.1 kod-ex32_1.htm EX-32.1 10550
5 EX-32.2 kod-ex32_2.htm EX-32.2 10542
  Complete submission text file 0000950170-24-097010.txt   4787213

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT kod-20240630.xsd EX-101.SCH 797219
42 EXTRACTED XBRL INSTANCE DOCUMENT kod-20240630_htm.xml XML 486702
Mailing Address 1200 PAGE MILL RD PALO ALTO CA 94304
Business Address 1200 PAGE MILL RD PALO ALTO CA 94304 650-281-0850
Kodiak Sciences Inc. (Filer) CIK: 0001468748 (see all company filings)

EIN.: 270476525 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38682 | Film No.: 241207762
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)